Reaction
Acute Promyelocytic Leukaemia reporting signals
As of the last recalculation, Acute Promyelocytic Leukaemia appears in 1,008 FAERS reports alongside 33 co-occurring drug terms. The strongest observed disproportionality signal is TRETINOIN (PRR 100.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tretinoin | 38 | 100.4 | 100.9 |
| Bleomycin Sulfate | 29 | 59.7 | 59.8 |
| Fluorouracil Cream, 0.5% | 125 | 38.5 | 38.6 |
| Fluorouracil | 125 | 37.9 | 38.0 |
| Vincristine Sulfate | 43 | 31.6 | 31.7 |
| Cytarabine | 78 | 29.0 | 29.0 |
| Etoposide | 91 | 28.0 | 28.0 |
| Cyclophosphamide Injection, Solution | 190 | 27.1 | 27.1 |
| Cyclophosphamide | 190 | 27.1 | 27.1 |
| Cyclophosphamide For Injection | 190 | 27.1 | 27.1 |
| Paclitaxel (Aibumin-Bound) | 81 | 22.0 | 22.1 |
| Busulfan | 16 | 21.3 | 21.3 |
| Ifosfamide | 20 | 19.6 | 19.6 |
| Paclitaxel | 82 | 18.5 | 18.5 |
| Oxaliplatin | 60 | 17.7 | 17.7 |
| Mercaptopurine | 14 | 16.9 | 16.9 |
| Exemestane | 16 | 15.7 | 15.7 |
| Capecitabine | 64 | 15.4 | 15.4 |
| Doxorubicin | 62 | 15.2 | 15.3 |
| Doxorubicin Hydrochloride | 23 | 14.9 | 14.9 |
| Melphalan | 15 | 13.8 | 13.8 |
| Thiotepa | 6 | 13.0 | 13.1 |
| Melphalan Hydrochloride | 15 | 12.5 | 12.5 |
| Goserelin | 8 | 12.4 | 12.4 |
| Docetaxel Anhydrous | 39 | 12.4 | 12.4 |
| Docetaxel | 39 | 12.4 | 12.4 |
| Ado-Trastuzumab Emtansine | 5 | 12.3 | 12.3 |
| Gefitinib | 5 | 11.5 | 11.5 |
| Imatinib | 9 | 10.6 | 10.6 |
| Olaparib | 9 | 9.0 | 9.0 |
| Carboplatin | 51 | 8.7 | 8.7 |
| Azacitidine For | 7 | 8.0 | 8.0 |
| Irinotecan Hydrochloride | 4 | 6.4 | 6.4 |